Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-10
DOI
10.1038/s41401-022-01040-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pyroptosis in inflammation-related respiratory disease
- (2022) Yuanyu Feng et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation
- (2022) Chengyi Dai et al. PHYTOMEDICINE
- Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases
- (2022) Haowen Xu et al. Acta Pharmaceutica Sinica B
- Natural products in drug discovery: advances and opportunities
- (2021) Atanas G. Atanasov et al. NATURE REVIEWS DRUG DISCOVERY
- Circadian Control of Inflammasome Pathways: Implications for Circadian Medicine
- (2020) Benoit Pourcet et al. Frontiers in Immunology
- Tabersonine ameliorates osteoblast apoptosis in rats with dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signalling pathway
- (2020) Xi Sun et al. AMB Express
- Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury
- (2020) Jian Zou et al. PHARMACOLOGICAL RESEARCH
- Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome
- (2019) Zhilei Wang et al. Acta Pharmaceutica Sinica B
- Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis
- (2019) Anja Pfalzgraff et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
- (2019) Zoltán Szekanecz et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
- (2019) Humayun Sharif et al. NATURE
- Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination
- (2018) Depeng Zhang et al. BIOCHEMICAL PHARMACOLOGY
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Advances in identification and validation of protein targets of natural products without chemical modification
- (2016) J. Chang et al. NATURAL PRODUCT REPORTS
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
- (2015) Hexin Shi et al. NATURE IMMUNOLOGY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast
- (2015) Yang Qu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
- (2014) J. J. Grailer et al. JOURNAL OF IMMUNOLOGY
- Synergistic and cytotoxic action of indole alkaloids produced from elicited cell cultures ofCatharanthus roseus
- (2012) Francisco Fernández-Pérez et al. PHARMACEUTICAL BIOLOGY
- The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
- (2011) Beckley K. Davis et al. Annual Review of Immunology
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
- (2010) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
- (2009) Luigi Franchi et al. NATURE IMMUNOLOGY
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search